Literature DB >> 3536609

Reproductive potential in the older woman.

P R Gindoff, R Jewelewicz.   

Abstract

There is a definite increase in the number of women bearing children in the 30- and 40-year-old age groups. The total number of women who are 35 to 40 years of age in the United States is projected to increase 42% and the percent births to this age group is projected to increase 37%. This is apparently because of a trend to postpone childbearing and first birth due to women's career priorities, advanced education, control over fertility, financial concerns, late and second marriages, and infertility. Associated with this is an increase in visits to the infertility specialist for older women who have an intrinsic decrease in fecundity with advancing age. Although, on the average, a woman will not experience menopause until about 50 years of age, her effective childbearing period may stop almost a decade earlier. A woman in her late 30s and, especially, early 40s is at some disadvantage in terms of conception delay, ability to carry a chromosomally normal fetus until term, and risk of trisomic conception. Certain endocrinologic parameters have been identified for the woman entering the transition to menopause. Biologic aging of the hypothalamic-pituitary-ovarian axis is intertwined with changes in the endocrine milieu of the perimenopause and preperimenopause. Despite a clear association of decreased fecundity in older women due to multiple biologic and social influences, so long as the individual has regular cycles and essentially normal endocrine parameters, she should be a candidate for an expedited infertility workup and ovulation induction, if not more aggressive treatment. Her obstetric profile is much improved, except for an increase in congenital anomalies and chromosomal defects. Chorionic villus biopsy study or amniocentesis is advised in all cases, regardless of therapy.

Entities:  

Keywords:  Abortion, Spontaneous; Age Factors--women; Animals, Laboratory; Biological Aging; Biology; Clinical Research; Contraceptive Usage; Demographic Factors; Economic Factors; Endocrine Effects; Endocrine System; Fecundability; Fecundity; Fertility; Fertilization; Follicle Stimulating Hormone; Genetics; Gonadotropins; Gonadotropins, Pituitary; Hormones; Literature Review; Luteinizing Hormone; Macroeconomic Factors; Maternal Age; Menopause; Ovulation; Parental Age; Physiology; Population; Population Characteristics; Population Dynamics; Pregnancy Complications; Reproduction; Reproductive Behavior; Reproductive Control Agents; Research And Development; Research Methodology; Sex Behavior; Socioeconomic Factors; Technology; Treatment

Mesh:

Year:  1986        PMID: 3536609     DOI: 10.1016/s0015-0282(16)49869-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Mother-daughter in vitro fertilization triplet surrogate pregnancy.

Authors:  M C Michelow; J Bernstein; M J Jacobson; J L McLoughlin; D Rubenstein; A I Hacking; S Preddy; I J Van der Wat
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

2.  Basal serum pituitary hormone levels and outcome of in vitro fertilization utilizing a flare nasal gonadotropin releasing hormone agonist and fixed low-dose follicle-stimulating hormone/human menopausal gonadotropin regimen.

Authors:  Y F Chan; P C Ho; W W So; W S Yeung
Journal:  J Assist Reprod Genet       Date:  1993-05       Impact factor: 3.412

3.  The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.

Authors:  A H Watt; A T Legedza; E S Ginsburg; R L Barbieri; R N Clarke; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

4.  Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Kutluk H Oktay; Charles E McCulloch; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-08-17       Impact factor: 6.860

5.  The value of hysteroscopy in elderly women prior to in vitro fertilization-embryo transfer (IVF-ET): a comparative study.

Authors:  D Dicker; J A Goldman; J Ashkenazi; D Feldberg; A Dekel
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-10

6.  The impact of embryo quality on pregnancy outcome in elderly women undergoing in vitro fertilization-embryo transfer (IVF-ET).

Authors:  D Feldberg; J Farhi; D Dicker; J Ashkenazi; M Shelef; J A Goldman
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-10

7.  The predictive value of basal follicle stimulating and growth hormone levels as determined by immunofluorometry during assisted reproduction.

Authors:  C Huyser; F L Fourie; J Pentz; P Hurter
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

8.  Psychiatric Morbidity in Infertility Patients in a Tertiary Care Setup.

Authors:  Pankaj Verma; Rajesh Rastogi; Soumya Sachdeva; Raghu Gandhi; Rohit Kapoor; Sarthak Sachdeva
Journal:  J Clin Diagn Res       Date:  2015-09-01

9.  Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters.

Authors:  L A van der Westerlaken; N Naaktgeboren; F M Helmerhorst
Journal:  J Assist Reprod Genet       Date:  1998-07       Impact factor: 3.412

10.  Risk of chromosomal abnormalities, with emphasis on live-born offspring of young mothers.

Authors:  B B Little; S M Ramin; B S Cambridge; N R Schneider; D S Cohen; L M Snell; M J Harrod; W L Johnston
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.